• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

4%阿替卡因与2%利多卡因对上颌不可逆性牙髓炎患者进行颊侧浸润麻醉的效果比较。

Comparison of anesthetic efficacy of 4% articaine and 2% lidocaine for maxillary buccal infiltration in patients with irreversible pulpitis.

作者信息

Srinivasan Narasimhan, Kavitha Mahendran, Loganathan Chandarasekaran S, Padmini Govindasamy

机构信息

Department of Conservative Dentistry, Tamilnadu Government Dental College and Hospital, Chennai-3, India.

出版信息

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009 Jan;107(1):133-6. doi: 10.1016/j.tripleo.2008.09.002.

DOI:10.1016/j.tripleo.2008.09.002
PMID:19101495
Abstract

OBJECTIVE

The purpose of this prospective, randomized, double-blind study was to compare the anesthetic efficacy of 4% articaine and 2% lidocaine (both with 1:100,000 epinephrine) for buccal infiltration in patients experiencing irreversible pulpitis in maxillary posterior teeth.

STUDY DESIGN

Forty patients with irreversible pulpitis in first premolar or first molar were divided into 4 study groups and received buccal infiltration of either 4% articaine or 2% lidocaine in a double-blind manner. Endodontic access was begun 5 minutes after solution deposition. Success was defined as no or mild discomfort (VAS recordings) during the endodontic procedure.

RESULTS

The success rate for maxillary buccal infiltration to produce pulpal anesthesia using articaine was 100% in first premolar and first molar, and for the lidocaine solution, success rate was 80% in first premolar and 30% in first molar. There was high significant difference between the articaine and lidocaine solutions (ANOVA; P < .001).

CONCLUSION

The efficacy of 4% articaine was superior to 2% lidocaine for maxillary buccal infiltration in posterior teeth.

摘要

目的

本前瞻性、随机、双盲研究的目的是比较4%阿替卡因和2%利多卡因(均含1:100,000肾上腺素)对上颌后牙不可逆性牙髓炎患者进行颊侧浸润麻醉的效果。

研究设计

40例第一前磨牙或第一磨牙患有不可逆性牙髓炎的患者被分为4个研究组,以双盲方式接受4%阿替卡因或2%利多卡因的颊侧浸润。在溶液注入5分钟后开始开髓。成功定义为在牙髓治疗过程中无不适或轻度不适(视觉模拟量表记录)。

结果

使用阿替卡因进行上颌颊侧浸润产生牙髓麻醉的成功率在第一前磨牙和第一磨牙中均为100%,而利多卡因溶液在第一前磨牙中的成功率为80%,在第一磨牙中为30%。阿替卡因溶液和利多卡因溶液之间存在高度显著差异(方差分析;P <.001)。

结论

4%阿替卡因在上颌后牙颊侧浸润麻醉的效果优于2%利多卡因。

相似文献

1
Comparison of anesthetic efficacy of 4% articaine and 2% lidocaine for maxillary buccal infiltration in patients with irreversible pulpitis.4%阿替卡因与2%利多卡因对上颌不可逆性牙髓炎患者进行颊侧浸润麻醉的效果比较。
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009 Jan;107(1):133-6. doi: 10.1016/j.tripleo.2008.09.002.
2
Anesthetic efficacy of the Gow-Gates injection and maxillary infiltration with articaine and lidocaine for irreversible pulpitis.采用阿替卡因和利多卡因进行下颌后牙区神经阻滞麻醉(Gow-Gates注射法)及上颌浸润麻醉用于不可逆性牙髓炎的麻醉效果
J Endod. 2008 Jun;34(6):656-9. doi: 10.1016/j.joen.2008.02.016. Epub 2008 Apr 25.
3
Anesthetic efficacy of supplemental buccal and lingual infiltrations of articaine and lidocaine after an inferior alveolar nerve block in patients with irreversible pulpitis.在下牙槽神经阻滞麻醉后,补充颊侧和舌侧注射阿替卡因和利多卡因对不可逆性牙髓炎患者的麻醉效果。
J Endod. 2009 Jul;35(7):925-9. doi: 10.1016/j.joen.2009.04.012.
4
A comparison of the efficacy of 4% articaine with 1:100,000 epinephrine and 2% lidocaine with 1:80,000 epinephrine in achieving pulpal anesthesia in maxillary teeth with irreversible pulpitis.比较含 1:100000 肾上腺素的 4%阿替卡因和含 1:80000 肾上腺素的 2%利多卡因在上颌牙髓炎牙齿中实现牙髓麻醉的效果。
J Endod. 2012 Mar;38(3):279-82. doi: 10.1016/j.joen.2011.11.010. Epub 2011 Dec 22.
5
Efficacy of articaine versus lidocaine in block and infiltration anesthesia administered in teeth with irreversible pulpitis: a prospective, randomized, double-blind study.在治疗不可复性牙髓炎的患牙中,使用阿替卡因行阻滞麻醉和浸润麻醉的效果对比:一项前瞻性、随机、双盲研究。
J Endod. 2013 Jan;39(1):6-10. doi: 10.1016/j.joen.2012.10.012. Epub 2012 Nov 13.
6
Efficacy of articaine and lidocaine in a primary intraligamentary injection administered with a computer-controlled local anesthetic delivery system.使用计算机控制局部麻醉药输送系统进行初次韧带内注射时阿替卡因和利多卡因的疗效。
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005 Mar;99(3):361-6. doi: 10.1016/j.tripleo.2004.11.009.
7
Comparison of 4% articaine with 1:100,000 epinephrine and 2% lidocaine with 1:100,000 epinephrine when used as a supplemental anesthetic.4%阿替卡因加1:100,000肾上腺素与2%利多卡因加1:100,000肾上腺素作为辅助麻醉剂时的比较。
J Endod. 2007 Apr;33(4):403-5. doi: 10.1016/j.joen.2006.11.019. Epub 2007 Feb 20.
8
Articaine for supplemental buccal mandibular infiltration anesthesia in patients with irreversible pulpitis when the inferior alveolar nerve block fails.当在下牙槽神经阻滞麻醉失败时,使用阿替卡因进行补充性颊下颌浸润麻醉用于患有不可逆性牙髓炎的患者。
J Endod. 2009 Mar;35(3):343-6. doi: 10.1016/j.joen.2008.11.025.
9
A prospective, randomized, double-blind comparison of articaine and lidocaine for maxillary infiltrations.阿替卡因与利多卡因用于上颌浸润麻醉的前瞻性、随机、双盲对照研究。
J Endod. 2008 Apr;34(4):389-93. doi: 10.1016/j.joen.2008.01.004. Epub 2008 Feb 7.
10
A comparison of the anesthetic efficacy of articaine and lidocaine in patients with irreversible pulpitis.阿替卡因与利多卡因在不可逆性牙髓炎患者中的麻醉效果比较。
J Endod. 2009 Feb;35(2):165-8. doi: 10.1016/j.joen.2008.10.020. Epub 2008 Dec 12.

引用本文的文献

1
Influence of Premedication and Dental Anxiety on Anesthetic Efficacy in Patients Undergoing Root Canal for Symptomatic Irreversible Pulpitis in Upper and Lower Molars: A Comparative Study of Articaine and Bupivacaine.术前用药和牙科焦虑对上下颌磨牙有症状不可逆性牙髓炎患者根管治疗麻醉效果的影响:阿替卡因与布比卡因的对比研究
Dent J (Basel). 2025 Apr 30;13(5):199. doi: 10.3390/dj13050199.
2
Articaine buccal infiltration for mandibular first molars with irreversible pulpitis: is the evidence enough?阿替卡因在下颌第一磨牙不可逆性牙髓炎的颊侧浸润麻醉:证据充分吗?
Evid Based Dent. 2025 May 6. doi: 10.1038/s41432-025-01153-4.
3
Comparison of the effects of lidocaine and articaine used for buccal infiltration and supplemental palatinal infiltration anesthesia in maxillary molars with irreversible pulpitis: a prospective randomized study.
利多卡因与阿替卡因用于上颌磨牙不可逆性牙髓炎颊侧浸润及补充腭侧浸润麻醉效果的比较:一项前瞻性随机研究。
BMC Oral Health. 2025 Feb 8;25(1):207. doi: 10.1186/s12903-025-05552-y.
4
Buccal versus buccal palatal infiltration for pulpal anesthesia using 2% lidocaine and 4% articaine: A randomized controlled trial.使用2%利多卡因和4%阿替卡因进行颊侧与颊腭侧浸润麻醉用于牙髓麻醉的随机对照试验。
J Oral Biol Craniofac Res. 2024 Mar-Apr;14(2):205-210. doi: 10.1016/j.jobcr.2024.02.004. Epub 2024 Feb 29.
5
Comparison of Efficacy of Lidocaine and Articaine as Inferior Alveolar Nerve Blocking Agents in Patients with Symptomatic Irreversible Pulpitis: Randomized Controlled Trial.比较利多卡因和阿替卡因作为有症状不可复性牙髓炎患者下牙槽神经阻滞麻醉剂的疗效:随机对照试验。
Medicina (Kaunas). 2023 Oct 16;59(10):1840. doi: 10.3390/medicina59101840.
6
Success of Pulpal Anesthesia Following Buccal Infiltration of the Maxillary First Molar With 1.8 mL and 3.6 mL of 4% Articaine With 1:100,000 Epinephrine: A Prospective, Randomized Crossover Study.上颌第一磨牙颊侧浸润注射 1.8 毫升和 3.6 毫升 4%阿替卡因含 1:100000 肾上腺素后牙髓麻醉效果的前瞻性随机交叉研究。
Anesth Prog. 2023 Sep 1;70(3):110-115. doi: 10.2344/anpr-70-03-01.
7
Posterior superior alveolar nerve block alone in the extraction of upper third molars: a prospective clinical study.单独使用上牙槽后神经阻滞麻醉在上颌第三磨牙拔除术中的应用:一项前瞻性临床研究
J Dent Anesth Pain Med. 2023 Aug;23(4):213-220. doi: 10.17245/jdapm.2023.23.4.213. Epub 2023 Jul 29.
8
Pulpal anesthesia of maxillary first molars using 4% articaine infiltration in patients with symptomatic irreversible pulpitis: a randomized controlled clinical trial.在有症状的不可逆性牙髓炎患者中使用4%阿替卡因浸润进行上颌第一磨牙牙髓麻醉:一项随机对照临床试验。
Clin Oral Investig. 2023 Jul;27(7):3999-4006. doi: 10.1007/s00784-023-05025-y. Epub 2023 May 27.
9
Comparative Evaluation of Buccal Infiltration Technique with Buccal Plus Palatal Infiltration Technique Using 4% Articaine in Patients with Irreversible Pulpitis of Maxillary 1 Molars: A Prospective, Randomized, Study.使用4%阿替卡因对上颌第一磨牙不可逆性牙髓炎患者进行颊侧浸润技术与颊侧加腭侧浸润技术的比较评价:一项前瞻性随机研究。
J Pharm Bioallied Sci. 2022 Oct-Dec;14(4):186-190. doi: 10.4103/jpbs.jpbs_545_22. Epub 2023 Feb 17.
10
Pain perception genes, asthma, and oral health: A reverse genetics study.疼痛感知基因、哮喘和口腔健康:反向遗传学研究。
PLoS One. 2022 Nov 17;17(11):e0277036. doi: 10.1371/journal.pone.0277036. eCollection 2022.